Publications by authors named "Rob Sellar"

Claim this Profile
C
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18.
Steven Knapper, Laura W Dillon, Malavika Babu, Abin Thomas, Ian Thomas, Rob S Sellar

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.
Nigel H Russell, Abin Thomas, Robert K Hills, Ian Thomas, Amanda Gilkes, Rob S Sellar

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.
Jad Othman, Angela Hwang, Maximillian Brodermann, Islam Abdallah, Kayleigh McCloskey, Rob Sellar

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clonal hematopoiesis mutation Jak2 aggravates endothelial injury and thrombosis in arteries with erosion-like intimas.
Roberto Molinaro, Rob S Sellar, Amélie Vromman, Grasiele Sausen, Eduardo Folco

Int J Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of targeted protein degradation to treat and study cancer.
Maximillian H Brodermann, Elizabeth K Henderson, Rob S Sellar

J Pathol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Jad Othman, Ing S Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Rob Sellar

Blood· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.
Sylvie D Freeman, Abin Thomas, Ian Thomas, Robert K Hills, Paresh Vyas, Rob S Sellar

Blood· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Clonal haematopoiesis and risk of chronic liver disease.
Waihay J Wong, Connor Emdin, Alexander G Bick, Seyedeh M Zekavat, Abhishek Niroula, Rob S Sellar

Nature· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal haematopoiesis and risk of chronic liver disease.
Waihay J Wong, Connor Emdin, Alexander G Bick, Seyedeh M Zekavat, Abhishek Niroula, Rob S Sellar

Nature· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells.
Rob S Sellar, Adam S Sperling, Mikołaj Słabicki, Jessica A Gasser, Marie E McConkey

J Clin Invest· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.
Aline Renneville, Jessica A Gasser, Daniel E Grinshpun, Pierre M Jean Beltran, Namrata D Udeshi, Rob S Sellar

Blood Cancer Discov· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
Mikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, Yen-Der Li, Manisha Manojkumar, Rob S Sellar

Nature· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
Rob S Sellar, Varun Mehra, Thomas A Fox, Andrew Grigg, Austin Kulasekararaj

Br J Haematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs.
Adam S Sperling, Michael Burgess, Hasmik Keshishian, Jessica A Gasser, Shruti Bhatt, Rob S Sellar

Blood· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jak-ing Up the Plaque's Lipid Core…and Even More.
Peter Libby, Roberto Molinaro, Rob S Sellar, Benjamin L Ebert

Circ Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells.
Josephine D Kahn, Peter G Miller, Alexander J Silver, Rob S Sellar, Shruti Bhatt

Blood· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting progression to AML.
Rob S Sellar, Siddhartha Jaiswal, Benjamin L Ebert

Nat Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
Rob S Sellar, Rosemary E Gale, Asim Khwaja, Maciej Garbowski, Marco Loddo

Br J Haematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.
Rob S Sellar, Clare Rowntree, Ajay J Vora, Caroline L Furness, Nicholas Goulden

Br J Haematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.
Ofir Wolach, Rob S Sellar, Kimberly Martinod, Deya Cherpokova, Marie McConkey

Sci Transl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Aberrant Signaling in Myeloid Malignancies: Promise Versus Reality.
Rob Sellar, Julie-Aurore Losman

Hematol Oncol Clin North Am· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.
Kile Green, Kim Pearce, Rob S Sellar, Laura Jardine, Phillip L R Nicolson

Biol Blood Marrow Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment.
Rob S Sellar, Laura Fraser, Asim Khwaja, Rosemary E Gale, Teresa Marafioti

Br J Haematol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation.
Dirk S Paul, Allison Jones, Rob S Sellar, Neema P Mayor, Andrew Feber

Genome Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients.
Rob S Sellar, Falko Fend, Ayse U Akarca, Claudio Agostinelli, Vishvesh Shende

Br J Haematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis